Sponsor intelligence · OTHER
Clinical trials sponsored by
Tianjin Medical University Cancer Institute And Hospital.
Real, source-linked trial activity for Tianjin Medical University Cancer Institute And Hospital: 17 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.
PHASE2 9NA 6N/A 1PHASE4 1
Newest Tianjin Medical University Cancer Institute And Hospital trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 2d ago | Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 6d ago | Risk-Stratified Management of Inavolisib-Induced Hyperglycemia and Pat | N/A | RECRUITING | ↗ |
| 6d ago | SBRT Combined With Reduced-Dose Anthracycline Chemotherapy and Toripal | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 17d ago | Phase II Study of Trastuzumab Rezetecan Combined With Retlirafusp Alfa | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 17d ago | Iparomlimab/Tuvonralimab Plus SBRT and Lenvatinib for Perioperative Tr | Ph 2 | RECRUITING | ↗ |
| 18d ago | IRE After Chemotherapy for Locally Advanced Pancreatic Cancer | NA | RECRUITING | ↗ |
| 18d ago | IRE After Targeted Immunotherapy in HCC With Portal Vein Tumor Thrombu | NA | RECRUITING | ↗ |
| 20d ago | HCCANANO-HOPE1: IRE After Chemotherapy for Locally Advanced Unresectab | NA | RECRUITING | ↗ |
| 30d ago | Adebrelimab Combined With Dalpiciclib Isethionate Plus Chemotherapy fo | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 31d ago | An Exploratory Study on the Efficacy and Safety of Enlonstobart Combin | Ph 4 | RECRUITING | ↗ |
| 44d ago | A Study on the Efficacy of Different Doses of Oryz-Aspergillus Enzyme | NA | NOT_YET_RECRUITING | ↗ |
| 52d ago | To Explore a Single-arm Phase II Study on Intestinal Microbiota Transp | NA | NOT_YET_RECRUITING | ↗ |
| 52d ago | Study on the Combined Treatment of Hepatocellular Carcinoma With Envaf | NA | NOT_YET_RECRUITING | ↗ |
| 53d ago | Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In U | Ph 2 | RECRUITING | ↗ |
| 58d ago | Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for | Ph 2 | RECRUITING | ↗ |
| 59d ago | Butyrate Yogurt for Cancer Constipation | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 60d ago | Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy | Ph 2 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Tianjin Medical University Cancer Institute And Hospital (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.